| C09CA03 |
Valsartan |
Sartoval |
Capsule, hard |
160 |
mg |
28 |
Тева Фармасютикълс България ЕООД, България |
80 |
mg |
- |
11.45 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1275/21.08.2012 г., корекц. КЦРР-1442/02.10.2012; НСР-638/29.07.2013; НСР-3813/16.06.2014. и КП-86/06.04.2015. |
02.04.2016 |
|
|
Активен |
2000 |
| C09CA03 |
Valsartan |
Suvartar |
Film coated tablet |
160 |
mg |
28 |
Sandoz d.d., Словения |
80 |
mg |
- |
11.45 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1753/04.12.2012 г.; НСР-1325/03.10.2013; НСР-5158/27.11.2014.; HCP-8620/31.03.2016.; НСР-11972/10.03.2017 |
02.04.2017 |
|
|
Активен |
3404 |
| C09CA03 |
Valsartan |
Valsacor |
Film coated tablet |
320 |
mg |
30 |
KRKA, d.d., Словения |
80 |
mg |
- |
15.06 |
0.1255 |
15.06 |
25% |
3.77 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-7507/19.11.2015. |
02.04.2016 |
|
|
Активен |
4143 |
| C09CA03 |
Valsartan |
Valsacor |
Film coated tablet |
160 |
mg |
28 |
KRKA, d.d., Словения |
80 |
mg |
- |
9.32 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 66/ 08.04.2010; № 79/10.05.2010; № 84/27.05.2010; НСР-1347/07.10.2013; НСР-3680/06.06.2014.; НСР-6782/23.07.2015.; НСР-10763/27.10.2016; НСР-14893/25.01.2018; НСР-18279/28.03.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2894 |
| C09CA03 |
Valsartan |
Valsalen |
Film coated tablet |
160 |
mg |
28 |
Екофарм Груп АД, България |
80 |
mg |
- |
14.05 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
HCР-227/21.06.2013.; НСР-16793/20.09.2018 |
02.11.2018 |
|
|
Активен |
1967 |
| C09CA03 |
Valsartan |
Valsarcon |
Film coated tablet |
160 |
mg |
30 |
Фармаконс АД, България |
80 |
mg |
- |
15.06 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-11666/10.02.2017; НСР-15664/17.05.2018 |
02.06.2018 |
|
|
Активен |
15593 |
| C09CA03 |
Valsartan |
Valsavil |
Film coated tablet |
160 |
mg |
30 |
Stada Arzneimittel AG, Германия |
80 |
mg |
- |
9.83 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-17453/06.12.2018 |
02.01.2019 |
|
|
Активен |
16373 |
| C09CA03 |
Valsartan |
Valstor |
Film coated tablet |
160 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
80 |
mg |
- |
20.68 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-850/15.06.2012 г. |
02.04.2016 |
08.09.2012 |
|
Активен |
1273 |
| C09CA03 |
Valsartan |
Valtensin |
Film coated tablet |
160 |
mg |
28 |
Актавис EАД, България |
80 |
mg |
- |
8.02 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 79/10.05.2010; КЦРР-872/28.06.2012 г.;НСР-128/07.06.2013НСР-2702/06.02.2014 |
02.04.2016 |
08.09.2012 |
|
Активен |
2474 |
| C09CA03 |
Valsartan |
Valtensin |
Film coated tablet |
320 |
mg |
28 |
Актавис EАД, България |
80 |
mg |
- |
17.63 |
0.1255 |
14.06 |
25% |
3.51 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
НСР-1388/10.10.2013; НСР-5309/ 18.12.2014.; НСР-8572/24.03.2016. |
02.05.2016 |
|
|
Активен |
3476 |
| C09CA03 |
Valsartan |
VALZAP |
Film coated tablet |
160 |
mg |
28 |
Zentiva k.s., Чешка република |
80 |
mg |
- |
10.2 |
0.1255 |
7.03 |
25% |
1.76 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
№ 92/23.06.2010; КЦРР-2224/06.02.2013 г.; НСР-2532/24.01.2014 |
02.06.2016 |
08.09.2012 |
|
Активен |
279 |
| C09CA03 |
Valsartan |
Vanatex |
Film coated tablet |
160 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
80 |
mg |
- |
14.6 |
0.1255 |
7.03 |
25% |
1.76 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1721/28.11.2012.; НСР-6061/16.04.2015. |
02.04.2016 |
|
|
Заличен |
3639 |
| C09CA03 |
Valsartan |
Vanatex |
Film coated tablet |
160 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
80 |
mg |
- |
14.6 |
0.09464 |
5.3 |
25% |
1.32 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1721/28.11.2012 г.; НСР-5769/09.03.2015; НСР-6061/16.04.2015. |
16.05.2015 |
|
|
Заличен |
3639 |
| C09CA03 |
Valsartan |
Vanatex |
Film coated tablet |
80 |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
80 |
mg |
- |
9.44 |
0.09464 |
2.65 |
25% |
0.66 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1721/28.11.2012 г.; НСР-5768/09.03.2015; НСР-6060/16.04.2015. |
16.05.2015 |
|
|
Заличен |
3638 |
| C09CA03 |
Valsartan |
Vapress |
Film coated tablet |
160 |
mg |
30 |
Medochemie Ltd., Кипър |
80 |
mg |
- |
12.94 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-2240/08.02.2013 г.; НСР-3311/24.04.2014.; HCP-8618/31.03.2016. |
02.05.2016 |
|
|
Активен |
2736 |
| C09CA03 |
Valsartan |
Walzera |
Film coated tablet |
160 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
80 |
mg |
- |
13.16 |
0.1255 |
7.53 |
25% |
1.88 |
|
I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2,I25.5,I50.0,I50.1 |
КЦРР-1731/04.12.2012 г.; HCР-8338/26.02.2016; НСР-16365/02.08.2018 |
02.09.2018 |
|
|
Заличен |
1479 |
| C09CA03 |
Valsartan |
Walzera |
Film coated tablet |
80 |
mg |
30 |
Alkaloid – INT d.o.o., Словения |
80 |
mg |
- |
10.44 |
0.26393 |
7.92 |
25% |
1.98 |
|
I10,I11,I12,I13,I25.5,I50.0,I50.1 |
КЦРР-1731/04.12.2012 г.; HCР-451/09.07.2013. |
02.08.2013 |
|
|
Заличен |
1478 |
| C09CA03 |
Valsartan 100% |
C09CA03 Valsartan 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C09CA03 |
Valsartan |
Diovan |
Film coated tablet |
160 |
mg |
28 |
Novartis Pharma GmbH, Германия |
80 |
mg |
11.93 |
- |
0.10567 |
5.92 |
100% |
5.92 |
|
I10 |
HCP-8879/13.04.2016; НСР-10742/27.10.2016; НСР-14820/18.01.2018 |
02.08.2019 |
08.09.2012 |
|
Активен |
3087 |
| C09CA03 |
Valsartan |
Sartoval |
Capsule, hard |
160 |
mg |
28 |
Тева Фармасютикълс България ЕООД, България |
80 |
mg |
9.65 |
- |
0.10567 |
5.92 |
100% |
5.92 |
|
I10 |
HCP-8884/13.04.2016. |
02.08.2019 |
|
|
Активен |
2000 |
| C09CA03 |
Valsartan |
Suvartar |
Film coated tablet |
160 |
mg |
28 |
Sandoz d.d., Словения |
80 |
mg |
9.65 |
- |
0.10567 |
5.92 |
100% |
5.92 |
|
I10 |
HCP-8887/13.04.2016.; HCP-8620/31.03.2016; НСР-11972/10.03.2017 |
02.08.2019 |
|
|
Активен |
3404 |
| C09CA03 |
Valsartan |
Valsacor |
Film coated tablet |
320 |
mg |
30 |
KRKA, d.d., Словения |
80 |
mg |
12.68 |
- |
0.10567 |
12.68 |
100% |
12.68 |
|
I10 |
HCP-8894/13.04.2016. |
02.08.2019 |
|
|
Активен |
4143 |
| C09CA03 |
Valsartan |
Valsacor |
Film coated tablet |
160 |
mg |
28 |
KRKA, d.d., Словения |
80 |
mg |
7.86 |
- |
0.10567 |
5.92 |
100% |
5.92 |
|
I10 |
HCP-8881/13.04.2016; НСР-10763/27.10.2016; НСР-14893/25.01.2018; НСР-18279/28.03.2019. |
02.08.2019 |
08.09.2012 |
|
Активен |
2894 |
| C09CA03 |
Valsartan |
Valsalen |
Film coated tablet |
160 |
mg |
28 |
Екофарм Груп АД, България |
80 |
mg |
11.84 |
- |
0.10567 |
5.92 |
100% |
5.92 |
|
I10 |
HCP-8889/13.04.2016.; НСР-16793/20.09.2018. |
02.08.2019 |
|
|
Активен |
1967 |
| C09CA03 |
Valsartan |
Valsarcon |
Film coated tablet |
160 |
mg |
30 |
Фармаконс АД, България |
80 |
mg |
12.68 |
- |
0.10567 |
6.34 |
100% |
6.34 |
|
I10 |
НСР-11666/10.02.2017; НСР-15664/17.05.2018 |
02.08.2019 |
|
|
Активен |
15593 |